Exosites: their current status, and their relevance to the duration of action of long-acting 2 -adrenoceptor agonists

Author： Coleman R.A. Johnson M. Nials A.T. Vardey C.J.

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.17, Iss.9, 1996-09, pp. : 324-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-acting 2-adrenoceptor agonists: increased risk of death?

Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Some Pharmacodynamic Aspects on Long-Acting -Adrenoceptor Agonists

By Waldeck B.

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 575-580

Elsevier

Access to resources Recommend Favorite

Effect of short- and long-acting 2 -adrenoceptor agonists on pulmonary 2 -adrenoceptor expression in human lung

By Nishikawa M. Mak J.C.W. Barnes P.J.

European Journal of Pharmacology, Vol. 318, Iss. 1, 1996-12 ,pp. : 123-129

Elsevier

Access to resources Recommend Favorite

Long-acting β₂ agonists

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 99-104

Informa Healthcare

Access to resources Recommend Favorite

Long-Acting 2-Adrenoceptor Agonists and Exercise-Induced Asthma: Lessons to Guide Us in the Future

By Anderson Sandra D. Brannan John D.

Pediatric Drugs, Vol. 6, Iss. 3, 2004-01 ,pp. : 161-175

Adis International

Access to resources Recommend Favorite